Stay updated on Pembrolizumab for Intermediate Risk NMIBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Intermediate Risk NMIBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Intermediate Risk NMIBC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page footer's revision label was incremented from v3.6.4 to v3.6.5, indicating a small update to the page metadata.
    Difference
    0.1%
    Check dated 2026-08-11T14:59:34.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page's revision stamp was updated from v3.6.3 to v3.6.4, replacing the previous revision with a newer version.
    Difference
    0.1%
    Check dated 2026-07-28T04:57:48.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.6.3, and older revision text along with links such as 'Bladder cancer' and 'MedlinePlus Genetics' were removed.
    Difference
    0.2%
    Check dated 2026-07-06T15:52:11.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous v3.6.0. This reflects a minor version update to the page template.
    Difference
    0.1%
    Check dated 2026-06-29T08:42:55.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Recruitment status shows no longer looking for participants. New user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) have been added, the Intervention/Treatment header formatting updated (from 'Intervention / Treatment' to 'Intervention/Treatment'), and the revision tag updated to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-15T06:00:38.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates a small software update to the site.
    Difference
    0.1%
    Check dated 2026-06-08T03:48:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Intermediate Risk NMIBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Intermediate Risk NMIBC Clinical Trial page.